Synjardy 12.5 mg/1 (Empagliflozin and Metformin Hydrochloride TABLET) 12.5 mg/1

Synjardy 12.5 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan. Learn more about Synjardy's uses and effects.

Strength

12.5 mg/1

Pack Size

60 TABLET in 1 BOTTLE (0597-0180-60)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy 12.5 mg/1 tablets are commonly used to help manage type 2 diabetes. This combination medication works by improving blood sugar control, often as part of a comprehensive treatment plan that includes diet and exercise. People may wonder, 'What is Synjardy used for?' Primarily, it aids in lowering blood glucose levels in adults with type 2 diabetes.

Side Effects

Common effects of Synjardy 12.5 mg/1 tablets may include symptoms like nausea, diarrhea, or headache. Some individuals might experience urinary tract infections or low blood sugar. These effects can vary, and it's important to monitor how your body responds to the medication.

Precautions & Warnings

Handle Synjardy 12.5 mg/1 tablets with care, especially if you have kidney problems or are on a low-sodium diet. Always follow your healthcare provider's advice regarding usage and storage. Keep the medication out of reach of children and pets.

Avoid Interactions

Synjardy 12.5 mg/1 tablets may interact with certain medications, including diuretics, insulin, or other diabetes drugs. Alcohol can also affect how this medication works. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

Synjardy 12.5 mg/1 tablets are used to help manage type 2 diabetes by improving blood sugar control.

Synjardy 12.5 mg/1 tablets are taken orally, typically with meals. Follow your healthcare provider's instructions for the best results.

Common side effects may include nausea, diarrhea, headache, and urinary tract infections. Always consult your healthcare provider if you experience severe or persistent effects.

Alcohol can interact with Synjardy 12.5 mg/1 tablets. It's best to consult your healthcare provider before consuming alcohol while on this medication.

People with severe kidney problems or those allergic to empagliflozin or metformin should avoid taking Synjardy 12.5 mg/1 tablets. Always consult your healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.